Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.

Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis. Am J Gastroenterol. 2021 01 01; 116(1):125-133.

View in: PubMed

subject areas

Antibodies, Monoclonal, Humanized
Anti-Inflammatory Agents, Non-Steroidal
Biological Products
Colitis, Ulcerative
Cost-Benefit Analysis
Deprescriptions
Drug Therapy, Combination
Gastrointestinal Agents
Humans
Infliximab
Markov Chains
Mesalamine
Piperidines
Protein Kinase Inhibitors
Pyrimidines
Quality-Adjusted Life Years

authors with profiles

David T. Rubin
Elbert Huang